Rhythm Pharmaceuticals (FRA:1RV) Beginning Cash Position : €45.8 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Rhythm Pharmaceuticals Beginning Cash Position?

Rhythm Pharmaceuticals's Beginning Cash Position for the quarter that ended in Dec. 2024 was €45.8 Mil.

Rhythm Pharmaceuticals's quarterly Beginning Cash Position increased from Jun. 2024 (€50.1 Mil) to Sep. 2024 (€146.1 Mil) but then declined from Sep. 2024 (€146.1 Mil) to Dec. 2024 (€45.8 Mil).

Rhythm Pharmaceuticals's annual Beginning Cash Position increased from Dec. 2022 (€56.2 Mil) to Dec. 2023 (€117.4 Mil) but then declined from Dec. 2023 (€117.4 Mil) to Dec. 2024 (€57.7 Mil).

Rhythm Pharmaceuticals Beginning Cash Position Historical Data

The historical data trend for Rhythm Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Pharmaceuticals Beginning Cash Position Chart

Rhythm Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

51.54

89.61

56.24

117.38

57.69

Rhythm Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial															59.53	55.58	50.06	146.08	45.83

Rhythm Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Rhythm Pharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Rhythm Pharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rhythm Pharmaceuticals Inc (FRA:1RV) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

RYTM:USA

Address

222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116

Website

https://www.rhythmtx.com

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Rhythm Pharmaceuticals Headlines

No Headlines